Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital

Microb Drug Resist. 2010 Mar;16(1):39-41. doi: 10.1089/mdr.2009.0084.

Abstract

Clinical and Laboratory Standards Institute changed penicillin susceptibility breakpoints for Streptococcus pneumoniae in 2008. After reevaluation with new breakpoints, resistance rates decreased from 6.1% to 0.5% for nonmeningitis and increased from 6.6% to 33.3% for meningitis isolates in our hospital. This breakpoint modification is expected to reduce the inconsistency between susceptibility results and therapeutic outcomes; however, both the clinical microbiology laboratories and the clinicians should be aware of the change to interpret the susceptibility results.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Academies and Institutes
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Hospitals, University
  • Humans
  • Laboratories, Hospital
  • Microbial Sensitivity Tests / standards*
  • Microbial Sensitivity Tests / statistics & numerical data
  • Penicillin Resistance*
  • Penicillins / pharmacology
  • Penicillins / therapeutic use
  • Pneumococcal Infections / drug therapy
  • Pneumococcal Infections / microbiology*
  • Streptococcus pneumoniae / drug effects*
  • Treatment Outcome
  • Turkey

Substances

  • Anti-Bacterial Agents
  • Penicillins